{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:11:38Z","timestamp":1793232698296,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016724","name":"Postgraduate Institute of Medical Education and Research, Chandigarh","doi-asserted-by":"publisher","award":["IEC - 12\/2017-777"],"award-info":[{"award-number":["IEC - 12\/2017-777"]}],"id":[{"id":"10.13039\/100016724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.vaccine.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T10:34:46Z","timestamp":1623321286000},"page":"4089-4098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cost effectiveness of typhoid vaccination in India"],"prefix":"10.1016","volume":"39","author":[{"given":"Akashdeep Singh","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-6006","authenticated-orcid":false,"given":"Saroj Kumar","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagandeep","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Prinja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.06.003_b0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.003_b0010","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: A call for coordinated action","volume":"62","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.003_b0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 - Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.003_b0020","first-page":"855","article-title":"Typhoid fever surveillance and vaccine use, South-East Asia and Western Pacific Regions, 2009\u20132013","volume":"63","author":"Date","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2021.06.003_b0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.003_b0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10111","key":"10.1016\/j.vaccine.2021.06.003_b0035","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2021.06.003_b0040","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.vaccine.2014.02.050","article-title":"Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children","volume":"32","author":"Szu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.06.003_b0045","unstructured":"World Health Organisation. Background Paper to SAGE on Typhoid Vaccine Policy Recommendations, 2017. Available from http:\/\/www.who.int\/immunization\/ sage\/ meetings\/2017\/october\/1_Typhoid_SAGE_background_ paper _Final_v3B.pdf. Accessed September 18, 2020."},{"key":"10.1016\/j.vaccine.2021.06.003_b0050","unstructured":"Typbar TCV\u00ae from Bharat Biotech, World\u2019s First Typhoid Conjugate Vaccine Prequalified by WHO [cited 2020 October 13]. Available from: https:\/\/www.who.int\/medicines\/news\/2017\/Bharat-Biotech-TypbarTCV-WHO-PQ-Press-Release-Global-Final.pdf?ua=1#:~:text=Krishna%20Ella%2C%20Chairman%20and%20Managing,term%20protection%20against%20typhoid%20fever."},{"key":"10.1016\/j.vaccine.2021.06.003_b0055","unstructured":"GAVI, The Vaccine Alliance. Millions of children set to be protected against typhoid fever. 2017. https:\/\/www.gavi.org\/library\/news\/press-releases\/2017\/millions-of-children-set-to-be-protected-againsttyphoid-fever\/ (accessed Oct 2, 2020)."},{"key":"10.1016\/j.vaccine.2021.06.003_b0060","unstructured":"GAVI, The Vaccine Alliance. List of eligible countries. https:\/\/www.gavi.org\/types-support\/sustainability\/eligibility. (accessed May 18, 2021)."},{"key":"10.1016\/j.vaccine.2021.06.003_b0065","unstructured":"Tan-Torres Edejer T, Baltussen R, Adam T. Making choices in health: WHO guide to cost-eff ectiveness analysis. Geneva: World Health Organization, 2003."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2021.06.003_b0070","doi-asserted-by":"crossref","first-page":"A88","DOI":"10.1016\/j.vaccine.2010.02.041","article-title":"India's National Technical Advisory Group on Immunisation","volume":"28","author":"John","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.003_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000259","article-title":"Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India","volume":"2","author":"Downey","year":"2017","journal-title":"BMJ Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.003_b0080","first-page":"311","article-title":"A cost-benefit analysis of typhoid fever immunization programmes in an Indian urban slum community","volume":"22","author":"Poulos","year":"2004","journal-title":"J Health Popul Nutr"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.003_b0085","first-page":"711","article-title":"Evaluating investments in typhoid vaccines in two slums in Kolkata","volume":"27","author":"Cook","year":"2009","journal-title":"India J Health Popul Nutr"},{"issue":"27","key":"10.1016\/j.vaccine.2021.06.003_b0090","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antill\u00f3n","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2021.06.003_b0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.003_b0100","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-5498-2","article-title":"Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts","author":"John","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2021.06.003_b0105","unstructured":"Department of Health Research, Ministry of Health and Family Welfare, Government of India. Health technology assessment in India: A manual. New Delhi: Department of Health Research; 2018."},{"issue":"11","key":"10.1016\/j.vaccine.2021.06.003_b0110","first-page":"77","article-title":"API recommendations for the management of typhoid fever","volume":"63","author":"Upadhyay","year":"2015","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.vaccine.2021.06.003_b0115","unstructured":"World Health Organization, Communicable Disease Surveillance and Response Vaccines and Biologicals. Background document: The diagnosis, treatment and prevention of typhoid fever [cited 2020 August 12]. Available from: https:\/\/www.glowm.com\/pdf\/WHO-diagnosis%20treatment%20prevention%20of%20typhoid%20fever-2003-CustomLicense.pdf."},{"issue":"7558","key":"10.1016\/j.vaccine.2021.06.003_b0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.333.7558.78","article-title":"Current concepts in the diagnosis and treatment of typhoid fever","volume":"333","author":"Bhutta","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2021.06.003_b0125","unstructured":"American Academy of Pediatrics. Salmonella Infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018:711-8."},{"key":"10.1016\/j.vaccine.2021.06.003_b0130","doi-asserted-by":"crossref","unstructured":"Cruz Espinoza LM, McCreedy E, Holm M, Im J, Mogeni OD, Parajulee P, et al. Occurrence of typhoid fever complications and their relation to duration of illness preceding hospitalization: A systematic literature review and meta-analysis. Clin Infect Dis. 2019; 30;69(Suppl 6):S435-S448.","DOI":"10.1093\/cid\/ciz477"},{"key":"10.1016\/j.vaccine.2021.06.003_b0135","doi-asserted-by":"crossref","unstructured":"Sur D, Barkume C, Mukhopadhyay B, Date K, Ganguly NK, Garrett D. A Retrospective Review of Hospital-Based Data on Enteric Fever in India, 2014-2015.J Infect Dis. 2018;218(suppl_4):S206-S213.","DOI":"10.1093\/infdis\/jiy502"},{"key":"10.1016\/j.vaccine.2021.06.003_b0140","unstructured":"Enteric Fever. Standard Treatment Guidelines. [cited 2020 Oct 2]. Available from: https:\/\/nhm.gov.in\/images\/pdf\/guidelines\/nrhm-guidelines\/stg\/enteric-fever.pdf."},{"key":"10.1016\/j.vaccine.2021.06.003_b0145","unstructured":"Paul UK. Typhoid Fever \u2013 Recent Management. [cited 2020 Oct 2]. Available from: http:\/\/apiindia.org\/wp-content\/uploads\/pdf\/medicine_update_2017\/mu_015.pdf."},{"key":"10.1016\/j.vaccine.2021.06.003_b0150","unstructured":"World Health Organization. Vaccine Preventable Diseases surveillance standards. Typhoid and other invasive salmonellosis [cited 2020 September 17]. Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/WHO_SurveillanceVaccinePreventable_21_Typhoid_R1.pdf?ua=1."},{"key":"10.1016\/j.vaccine.2021.06.003_b0155","unstructured":"Registrar General & Census Commissioner of India. SRS based abridges life tables 2013-17. [cited 2020 13 April]. Available from: http:\/\/censusindia.gov.in\/Vital_Statistics\/SRS_Life_Table\/SRS%20based%20Abridged%20Life%20Tables%202013-17.pdf."},{"key":"10.1016\/j.vaccine.2021.06.003_b0160","unstructured":"Government of India, Ministry of Statistics and Programme Implementation, National Sample Survey Organization (NSSO). NSSO 75th Round (July 2017\u2013June 2018): Key indicators of social consumption in India health. New Delhi: Ministry of Statistics and Programme Implementation; 2019."},{"key":"10.1016\/j.vaccine.2021.06.003_b0165","unstructured":"Government of India. Ministry of Health and Family Welfare. National Family Health Survey (NFHS-4): 2015-16 [cited 2020 September 5]. Available from: http:\/\/rchiips.org\/nfhs\/NFHS-4Reports\/India.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.003_b0170","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.06.003_b0175","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.vhri.2019.11.003","article-title":"Addressing the cost data gap for universal healthcare coverage in India: A call to action","volume":"21","author":"Prinja","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"7","key":"10.1016\/j.vaccine.2021.06.003_b0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035170","article-title":"Establishing reference costs for the health benefit packages under universal health coverage in India: cost of health services in India (CHSI) protocol","volume":"10","author":"Prinja","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.vaccine.2021.06.003_b0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232873","article-title":"Process evaluation of health system costing - Experience from CHSI study in India","volume":"15","author":"Prinja","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.003_b0190","unstructured":"Government of India, Ministry of Statistics and Programme Implementation, National Sample Survey Organization (NSSO). NSSO 71st Round (January\u2013June 2014): Key indicators of social consumption in India health. New Delhi: Ministry of Statistics and Programme Implementation; 2015."},{"key":"10.1016\/j.vaccine.2021.06.003_b0195","unstructured":"Kumar D, Sharma A, Rana SK, Prabha K, Karthikeyan AS, Ramanujam K, et al. Cost of illness due to severe enteric fever in India. Unpublished."},{"key":"10.1016\/j.vaccine.2021.06.003_b0200","unstructured":"Kabra SK, Lodha R. Pediatri Intensive Care Protocols of AIIMS. 2nd ed. New Delhi: Indian J Pediatrics; 2017."},{"key":"10.1016\/j.vaccine.2021.06.003_b0205","unstructured":"Singhi SC. PGIMER Management Protocols In Emergency Medicine. 2nd ed. New Delhi: Indian J Pediatrics; 2016."},{"key":"10.1016\/j.vaccine.2021.06.003_b0210","unstructured":"World Bank. GDP Deflator - India [cited 2020 August 25]. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.DEFL.ZS?locations=IN."},{"key":"10.1016\/j.vaccine.2021.06.003_b0215","unstructured":"The World Bank. GDP per capita - India [cited 2020 October 15]. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=IN."},{"key":"10.1016\/j.vaccine.2021.06.003_b0220","unstructured":"Postgraduate Institute of Medical Education and Research. Outcome report of Development of Health Related Quality of Life (EQ-5D-5L) Value set for India. New Delhi: Department of Health Research, Ministry of Health and Family Welfare, Government of India; 2020."},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.003_b0225","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3390\/ijerph15061174","article-title":"Cost-of-illness and the health-related quality of life of patients in the dengue fever outbreak in hanoi in 2017","volume":"15","author":"Tran","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2021.06.003_b0230","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/s12879-017-2801-2","article-title":"The impact of influenza on the health related quality of life in China: an EQ-5D survey","volume":"17","author":"Yang","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2021.06.003_b0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med Decis Making"},{"key":"10.1016\/j.vaccine.2021.06.003_b0240","first-page":"725","article-title":"Treatment cost for typhoid fever at two hospitals in Kolkata","volume":"27","author":"Sur","year":"2009","journal-title":"India J Heal Popul Nutr"},{"key":"10.1016\/j.vaccine.2021.06.003_b0245","first-page":"304","article-title":"Costs of illness due to typhoid fever in an Indian urban slum community: implications for vaccination policy","volume":"22","author":"Bahl","year":"2004","journal-title":"J Heal Popul Nutr Bangladesh"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2021.06.003_b0250","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/cid\/ciy1122","article-title":"A review of the economic evidence of typhoid fever and typhoid vaccines","volume":"68","author":"Luthra","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2021.06.003_b0255","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004549","article-title":"Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries","volume":"6","author":"Nemzoff","year":"2021","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2021.06.003_b0260","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-039517","article-title":"Valuing health-related quality of life among the Indian population: a protocol for the Development of an EQ-5D Value set for India using an Extended design (DEVINE) Study","volume":"10","author":"Jyani","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.vaccine.2021.06.003_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238291","article-title":"Cost effectiveness of strategies for cervical cancer prevention in India","volume":"15","author":"Chauhan","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.06.003_b0270","article-title":"Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India","volume":"1\u20138","author":"Chauhan","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.vaccine.2021.06.003_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221769","article-title":"Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India","volume":"14","author":"Chugh","year":"2019","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2021.06.003_b0280","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s11136-010-9648-y","article-title":"Development of the EQ-5D-Y: a child-friendly version of the EQ-5D","volume":"19","author":"Wille","year":"2010","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1016\/j.vaccine.2021.06.003_b0285","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jval.2018.05.002","article-title":"Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective","volume":"21","author":"Kreimeier","year":"2018","journal-title":"Value Health"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2021.06.003_b0290","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/ciy1108","article-title":"Predicting the impact of typhoid conjugate vaccines on antimicrobial resistance","volume":"68","author":"Kaufhold","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2021.06.003_b0295","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.75.3.214","article-title":"Impact of age and drug resistance on mortality in typhoid fever","volume":"75","author":"Bhutta","year":"1996","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.003_b0300","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.05.020407","article-title":"Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever","volume":"5","author":"Azmatullah","year":"2015","journal-title":"J Glob Health"},{"issue":"2","key":"10.1016\/j.vaccine.2021.06.003_b0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/ijmr.IJMR_199_18","article-title":"Current antibiotic use in the treatment of enteric fever in children","volume":"149","author":"Dahiya","year":"2019","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2021.06.003_b0310","doi-asserted-by":"crossref","DOI":"10.4103\/ijph.IJPH_433_18","article-title":"Private sector vaccine share in overall immunization coverage in India: Evidence from private sector vaccine utilization data (2012\u20132015)","author":"Farooqui","year":"2020","journal-title":"Indian J Public Health"},{"key":"10.1016\/j.vaccine.2021.06.003_b0315","unstructured":"World Health Organization. Market Information for Access to Vaccines. Global Market Study: Typhoid Vaccines [cited 2021 May 15]. Available from: https:\/\/www.who.int\/immunization\/programmes_systems\/procurement\/mi4a\/platform\/module2\/Typhoid_Vaccines-Market_Study_Public_Summary-November2020.pdf?ua=1."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21007131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:59:01Z","timestamp":1759402741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21007131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":63,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0264410X21007131"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost effectiveness of typhoid vaccination in India","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}